Bladder cancer screening for people at higher risk
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests screening for bladder cancer in people who have higher risk due to age, smoking, and certain job exposures. It may help find bladder cancer earlier when treatment can be more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 50 or older
- Have smoked at least 15 pack-years (a measure of how much and how long you smoked)
- Have had at least 15 years of job exposure as a textile worker, painter, or dry cleaner
- Have never been diagnosed with bladder cancer, kidney cancer, or prostate cancer
- Have not had medical evaluation for blood in the urine (microscopic or visible) within the last 2 years
- Be able and willing to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether a new lab test on urine can help sort out which people with small amounts of blood in the urine (microscopic hematuria) might have bladder cancer. It may help doctors evaluate symptoms more accurately and decide who needs further testing.
This study is testing a urine test to see if it can find bladder cancer early in people with Lynch syndrome. If you have Lynch syndrome and are between 50 and 75, this screening could help catch cancer before it causes symptoms.
This study looks at urothelial cancer (often bladder cancer) samples taken during diagnosis or standard treatment. It may help researchers better understand the disease by using tissue that doctors already need to collect for care.
This trial is testing a urine test called Bladder EpiCheck to see if it can help find bladder cancer in people who have blood in their urine. You would give a urine sample and then have a standard cystoscopy as part of your care.
This trial collects clinical samples from adults who have suspected or confirmed urothelial (bladder/urinary tract lining) cancer. It helps researchers study the disease and may support future improvements in diagnosis or treatment.
This study collects urine samples to test UroAmp, a new genetic test that may help detect and monitor bladder cancer. It is for people with bladder cancer or blood in urine who want to help improve cancer detection.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.